Table 2. Pathologic outcomes of RP.
| Pathologic outcomes | Values | |
|---|---|---|
| High-grade PIN | 120 (59.1) | |
| Lymphovascular invasion | 10 (4.9) | |
| Perineural invasion | 113 (59.1) | |
| Gleason score | ||
| 5 | 1 (0.5) | |
| 6 | 52 (25.6) | |
| 7 (3 + 4) | 76 (37.4) | |
| 7 (4 + 3) | 60 (29.6) | |
| 8 | 9 (4.4) | |
| 9 | 5 (2.5) | |
| Pathologic T stage | ||
| T2a | 25 (12.3) | |
| T2b | 13 (6.4) | |
| T2c | 65 (32.0) | |
| T3a | 88 (43.3) | |
| T3b | 9 (4.4) | |
| T4 | 3 (1.5) | |
| Positive surgical margin | 53 (26.1) | |
| Favorable IRPCa | ||
| RP pathologya | 38 (18.7) | |
| Established criteria I | 108 (53.2) | |
| Established criteria II | 75 (36.9) | |
Values are presented as number (%).
RP = radical prostatectomy, PIN = prostatic intraepithelial neoplasia, IRPCa = intermediate-risk prostate cancer.
aFavorable pathology was defined as a Gleason score ≤ 6 and organ-confined cancer as detected by surgical pathology.